Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
ACS Synth Biol ; 10(3): 505-514, 2021 03 19.
Article in English | MEDLINE | ID: mdl-33587591

ABSTRACT

Quantifying the binding affinity of protein-protein interactions is important for elucidating connections within biochemical signaling pathways, as well as characterization of binding proteins isolated from combinatorial libraries. We describe a quantitative yeast-yeast two-hybrid (qYY2H) system that not only enables the discovery of specific protein-protein interactions but also efficient, quantitative estimation of their binding affinities (KD). In qYY2H, the bait and prey proteins are expressed as yeast cell surface fusions using yeast surface display. We developed a semiempirical framework for estimating the KD of monovalent bait-prey interactions, using measurements of bait-prey yeast-yeast binding, which is mediated by multivalent interactions between yeast-displayed bait and prey. Using qYY2H, we identified interaction partners of SMAD3 and the tandem WW domains of YAP from a cDNA library and characterized their binding affinities. Finally, we showed that qYY2H could also quantitatively evaluate binding interactions mediated by post-translational modifications on the bait protein.


Subject(s)
Protein Interaction Maps , Saccharomyces cerevisiae/metabolism , Smad3 Protein/metabolism , Transcription Factors/metabolism , Gene Library , Genes, Reporter , Protein Binding , Protein Domains , Saccharomyces cerevisiae/genetics , Smad3 Protein/chemistry , Transcription Factors/chemistry , Two-Hybrid System Techniques
2.
ACS Comb Sci ; 22(10): 519-532, 2020 10 12.
Article in English | MEDLINE | ID: mdl-32786323

ABSTRACT

Cyclic peptides with engineered protein-binding activity have gained increasing attention for use in therapeutic and biotechnology applications. We describe the efficient isolation and characterization of cyclic peptide binders from genetically encoded combinatorial libraries using yeast surface display. Here, peptide cyclization is achieved by disuccinimidyl glutarate-mediated cross-linking of amine groups within a linear peptide sequence that is expressed as a yeast cell surface fusion. Using this approach, we first screened a library of cyclic heptapeptides using magnetic selection, followed by fluorescence activated cell sorting (FACS) to isolate binders for a model target (lysozyme) with low micromolar binding affinity (KD ∼ 1.2-3.7 µM). The isolated peptides bind lysozyme selectively and only when cyclized. Importantly, we showed that yeast surface displayed cyclic peptides can be used to efficiently obtain quantitative estimates of binding affinity, circumventing the need for chemical synthesis of the selected peptides. Subsequently, to demonstrate broader applicability of our approach, we isolated cyclic heptapeptides that bind human interleukin-17 (IL-17) using yeast-displayed IL-17 as a target for magnetic selection, followed by FACS using recombinant IL-17. Molecular docking simulations and follow-up experimental analyses identified a candidate cyclic peptide that likely binds IL-17 in its receptor binding region with moderate apparent affinity (KD ∼ 300 nM). Taken together, our results show that yeast surface display can be used to efficiently isolate and characterize cyclic peptides generated by chemical modification from combinatorial libraries.


Subject(s)
Cell Membrane/chemistry , Interleukin-17/chemistry , Peptides, Cyclic/isolation & purification , Recombinant Proteins/chemistry , Saccharomyces cerevisiae/chemistry , Biophysical Phenomena , Cyclization , Flow Cytometry , Humans , Molecular Docking Simulation , Peptide Library , Protein Binding , Protein Conformation , Protein Engineering , Saccharomyces cerevisiae/ultrastructure , Structure-Activity Relationship , Surface Properties
3.
Neuropsychology ; 34(1): 24-30, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31219297

ABSTRACT

INTRODUCTION: Parkinson's disease (PD) is a neurodegenerative disorder that commonly results in cognitive impairments and dementia. Intraindividual variability of neuropsychological performance is a sensitive marker of cognitive decline in other neurologic populations. However, studies have not examined the longitudinal utility of intraindividual variability in predicting future cognitive impairments among individuals with PD. In the current study, we hypothesized that increased intraindividual variability would predict future cognitive decline independent of traditional neuropsychological markers of cognitive impairment. METHODS: The sample included 423 newly diagnosed PD patients and 175 healthy controls, who were followed up to 5 years (baseline, first, second, third, fourth, and fifth annual follow-up). Participants underwent tests of learning, memory, processing speed, attention, verbal fluency, and visuospatial functioning. Cognitive status (cognitive intact, mild cognitive impairment, and dementia) was classified based on previously established criteria. Multilevel models were computed to examine the longitudinal relationship between intraindividual variability, cognitive status, and general cognitive functioning. RESULTS: Analyses revealed that increased intraindividual variability was predictive of incident cognitive decline among individuals with PD. Specifically, greater dispersion in neuropsychological performance was associated with greater risk of transitioning from cognitively intact to mild cognitive impairment or transitioning from mild cognitive impairment to dementia. Additional analyses revealed a significant Intraindividual Variability × Group (PD or control) interaction, meaning that intraindividual variability was predictive of declines in cognitive functioning among PD participants only but not healthy controls. CONCLUSION: Intraindividual variability may be a harbinger for future cognitive decline among individuals with PD. (PsycINFO Database Record (c) 2020 APA, all rights reserved).


Subject(s)
Cognition Disorders/etiology , Cognition Disorders/psychology , Neuropsychological Tests , Parkinson Disease/complications , Parkinson Disease/psychology , Psychomotor Performance , Aged , Attention , Cognition Disorders/diagnosis , Cognitive Dysfunction/etiology , Cognitive Dysfunction/psychology , Female , Follow-Up Studies , Humans , Individuality , Learning , Longitudinal Studies , Male , Memory , Middle Aged , Reaction Time , Reproducibility of Results , Space Perception , Verbal Behavior
4.
ACS Comb Sci ; 21(12): 817-832, 2019 12 09.
Article in English | MEDLINE | ID: mdl-31693340

ABSTRACT

When isolating binders from yeast displayed combinatorial libraries, a soluble, recombinantly expressed form of the target protein is typically utilized. As an alternative, we describe the use of target proteins displayed as surface fusions on magnetized yeast cells. In our strategy, the target protein is coexpressed on the yeast surface with an iron oxide binding protein; incubation of these yeast cells with iron oxide nanoparticles results in their magnetization. Subsequently, binder cells that interact with the magnetized target cells can be isolated using a magnet. Using a known binder-target pair with modest binding affinity (KD ≈ 400 nM), we showed that a binder present at low frequency (1 in 105) could be enriched more than 100-fold, in a single round of screening, suggesting feasibility of screening combinatorial libraries. Subsequently, we screened yeast display libraries of Sso7d and nanobody variants against yeast displayed targets to isolate binders specific to the cytosolic domain of the mitochondrial membrane protein TOM22 (KD ≈ 272-1934 nM) and the extracellular domain of the c-Kit receptor (KD ≈ 93 to KD > 2000 nM). Additional studies showed that the TOM22 binders identified using this approach could be used for the enrichment of mitochondria from cell lysates, thereby confirming binding to the native mitochondrial protein. The ease of expressing a membrane protein or a domain thereof as a yeast cell surface fusion-in contrast to recombinant soluble expression-makes the use of yeast-displayed targets particularly attractive. Therefore, we expect the use of magnetized yeast cell targets will enable efficient isolation of binders to membrane proteins.


Subject(s)
Ferric Compounds/pharmacology , Mitochondrial Membrane Transport Proteins/antagonists & inhibitors , Nanoparticles/chemistry , Saccharomyces cerevisiae Proteins/antagonists & inhibitors , Saccharomyces cerevisiae/drug effects , Small Molecule Libraries/pharmacology , Combinatorial Chemistry Techniques , Drug Evaluation, Preclinical , Ferric Compounds/chemistry , Magnetic Phenomena , Mitochondria/drug effects , Mitochondria/metabolism , Mitochondrial Membrane Transport Proteins/isolation & purification , Mitochondrial Membrane Transport Proteins/metabolism , Protein Binding/drug effects , Saccharomyces cerevisiae/cytology , Saccharomyces cerevisiae/metabolism , Saccharomyces cerevisiae Proteins/isolation & purification , Saccharomyces cerevisiae Proteins/metabolism , Small Molecule Libraries/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...